Skip to content
ClinCalc Pro
Menu
Alkalinising IV solution

Sodium bicarbonate with sodium chloride

Used in: Acute Kidney Injury Poisoning & Overdose Hyperkalaemia Hyponatraemia

This is an intravenous solution combining sodium bicarbonate with sodium chloride, used to provide bicarbonate buffering together with sodium and fluid replacement.

Dosing — no UK product information found

We found no UK product information (SmPC) for this medicine or presentation on the eMC or MHRA Products (checked October 2026). It may be unlicensed in the UK, imported, a medical device, or no longer marketed. ClinCalc Pro shows only doses it can trace to official product information, so none is shown — follow your specialist service or local guideline.

Clinical monograph

How it works

Bicarbonate buffers excess hydrogen ions to raise blood pH, while sodium chloride contributes to sodium and extracellular volume replacement.

Prescribing in practice

  • The combined sodium from both components gives a substantial sodium load, so it should be used cautiously in cardiac failure, hypertension and oedematous states and avoided in metabolic or respiratory alkalosis.
  • Over-administration can cause metabolic alkalosis, hypokalaemia, hypocalcaemia and hypernatraemia, so dosing should be guided by acid-base and electrolyte results.
  • It should not be co-administered through the same line as calcium-containing solutions because of the risk of precipitation.

Monitoring

Monitor arterial blood gases, serum electrolytes including potassium and calcium, and fluid balance during administration.

Counselling the patient

  • Explain that this drip helps correct acid levels in the blood and replaces salt and fluid.
  • Report swelling, breathlessness or discomfort at the infusion site.

Evidence & guidelines

Sodium bicarbonate therapy is reserved for specific indications such as significant metabolic acidosis, with electrolyte and acid-base monitoring guiding its use.

Reference: UK guidelines; TOXBASE; Confirm identity and dosing against the manufacturer SPC (eMC) and NICE. Verify against your local formulary and current prescribing references before prescribing. Monograph status: clinician-reviewed (2026-07-04).

Related

Curated clinical cross-links plus same-class fallbacks.